Author: BusinessWire

March 18, 2021 Off

AV-101: A New Generation of Investigational Medicines in Neuropsychiatry and Neurology Known as NMDA Glutamate Receptor Modulators – Global Emerging Insight and Market Forecast to 2030 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “AV-101 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

AV-101 (4-Cl-KYN) belongs to a new generation of investigational medicines in neuropsychiatry and neurology…

March 18, 2021 Off

AV-101: A New Generation of Investigational Medicines in Neuropsychiatry and Neurology Known as NMDA Glutamate Receptor Modulators – Global Emerging Insight and Market Forecast to 2030 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “AV-101 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

AV-101 (4-Cl-KYN) belongs to a new generation of investigational medicines in neuropsychiatry and neurology…

March 18, 2021 Off

AV-101: A New Generation of Investigational Medicines in Neuropsychiatry and Neurology Known as NMDA Glutamate Receptor Modulators – Global Emerging Insight and Market Forecast to 2030 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “AV-101 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

AV-101 (4-Cl-KYN) belongs to a new generation of investigational medicines in neuropsychiatry and neurology…

March 18, 2021 Off

AV-101: A New Generation of Investigational Medicines in Neuropsychiatry and Neurology Known as NMDA Glutamate Receptor Modulators – Global Emerging Insight and Market Forecast to 2030 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “AV-101 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

AV-101 (4-Cl-KYN) belongs to a new generation of investigational medicines in neuropsychiatry and neurology…